April 23 (Reuters) - RELIEF THERAPEUTICS Holding SA:
* ANNOUNCES THAT IT HAS GRANTED AN OPTION TO LICENSE AVIPTADIL TO SEREN CLINICAL
* PRE-NEGOTIATED FINANCIAL TERMS OF PUTATIVE FUTURE LICENSING AGREEMENT NOT DISCLOSED Further company coverage: (Gdynia Newsroom)